ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $46,562,000 | +37.1% | 813,600 | +16.2% | 1.24% | +114.9% |
Q2 2018 | $33,964,000 | +24.1% | 700,000 | 0.0% | 0.58% | +19.9% |
Q1 2018 | $27,370,000 | -7.9% | 700,000 | 0.0% | 0.48% | -4.2% |
Q4 2017 | $29,708,000 | +13.7% | 700,000 | 0.0% | 0.50% | +16.7% |
Q3 2017 | $26,124,000 | +22.8% | 700,000 | 0.0% | 0.43% | +31.7% |
Q2 2017 | $21,273,000 | +14.8% | 700,000 | 0.0% | 0.33% | -8.6% |
Q1 2017 | $18,529,000 | +45.2% | 700,000 | +40.0% | 0.36% | +26.0% |
Q4 2016 | $12,760,000 | +17.5% | 500,000 | +66.7% | 0.28% | +28.4% |
Q3 2016 | $10,857,000 | – | 300,000 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 1,505,012 | $204,095,000 | 39.96% |
Foresite Capital Management III, LLC | 108,630 | $14,731,000 | 12.94% |
Avoro Capital Advisors LLC | 3,000,000 | $406,830,000 | 7.03% |
Octagon Capital Advisors LP | 112,363 | $15,238,000 | 5.74% |
Artal Group S.A. | 1,400,000 | $189,854,000 | 3.36% |
Eversept Partners, LP | 241,981 | $32,815,043 | 2.47% |
NWI MANAGEMENT LP | 200,000 | $27,122,000 | 2.26% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,500 | $8,199,000 | 2.17% |
Affinity Asset Advisors, LLC | 45,000 | $6,102,000 | 2.07% |
Parkman Healthcare Partners LLC | 62,780 | $8,514,000 | 1.98% |